Equity Considerations in CEA: Rotavirus Vaccine in LMIC's
2018
The authors used a systematic review of the literature to identify economic evaluations of rotavirus vaccine in LMICs and assess the extent to which equity was considered in the objectives, analysis, and results. They used equity-related indicators provided in the Guidance on Priority Setting in Health Care (GPS-Health) checklist criteria resulting in 18 unique indicators tracked. The authors found that some articles incorporated the indicators in their model inputs (20%) while the majority (80%) presented results (costs, health outcomes, or incremental cost-effectiveness ratios) differentiated according to the indicators and that less than a fifth of articles that incorporated indicators did so due to an explicit study objective related to capturing equity considerations.
Equity Considerations in CEA: Rotavirus Vaccine in LMIC's
Source:
Boujaoude M, Mirelman AJ, Dalziel K et al. Accounting for Equity Considerations in Cost-Effectiveness Analysis: A Systematic Review of Rotavirus Vaccine in Low- and Middle-Income Countries. Cost Effectiveness and Resource Allocation 2018; 16 (18). https://doi.org/10.1186/s12962-018-0102-2